ABBOTT INDIA
Back to Balance Sheet
|
ABBOTT INDIA Last 5 Year Deferred Tax Assets / Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-15 Cr | ₹-16 Cr | ₹-17 Cr | ₹-17 Cr | ₹-18 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of ABBOTT INDIA ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹-15 Cr |
Mar2024 | ₹-16 Cr |
Mar2023 | ₹-17 Cr |
Mar2022 | ₹-17 Cr |
Mar2021 | ₹-18 Cr |
How is Deferred Tax Assets / Liabilities of ABBOTT INDIA Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹-15 Cr | Negative | |
Mar2024 | ₹-16 Cr | Negative | |
Mar2023 | ₹-17 Cr | Negative | |
Mar2022 | ₹-17 Cr | Negative | |
Mar2021 | ₹-18 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of ABBOTT INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ABBOTT INDIA | ₹66,759.6 Cr | -3.4% | -4.2% | 10.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,466.0 Cr | -3.3% | -6.9% | -9.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,423.0 Cr | 1.7% | -6.8% | 25.4% | Stock Analytics | |
CIPLA | ₹128,405.0 Cr | -0.9% | 0.5% | -0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,111.0 Cr | -1.9% | -1.3% | 7.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,408.0 Cr | -1.2% | -2% | -9% | Stock Analytics |
ABBOTT INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ABBOTT INDIA | -3.4% |
-4.2% |
10.1% |
SENSEX | -2.2% |
-1.7% |
-1.2% |
You may also like the below Video Courses